Nuveen, LLC Akebia Therapeutics, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 350,413 shares of AKBA stock, worth $847,999. This represents 0.0% of its overall portfolio holdings.
Number of Shares
350,413Holding current value
$847,999% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AKBA
# of Institutions
133Shares Held
70.2MCall Options Held
50.6KPut Options Held
203K-
Vanguard Group Inc Valley Forge, PA12.7MShares$30.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$28.2 Million0.0% of portfolio
-
State Street Corp Boston, MA6.3MShares$15.3 Million0.0% of portfolio
-
Satter Management Co., L.P.5.75MShares$13.9 Million20.26% of portfolio
-
Geode Capital Management, LLC Boston, MA5.03MShares$12.2 Million0.0% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $445M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...